Reviva Pharmaceuticals reported the completion of a $15.83 million financing round


reviva pharma$15.83 million was raised by Reviva Pharmaceuticals following the successful placement and issuance of its unregistered equity securities. A total of forty-seven investors participated to the non-brokered placement which started almost two weeks ago. Two previous unregistered financing rounds raised an estimated $19.66 million.

Reviva Pharmaceuticals develops new drugs for the central nervous system, metabolic, cardiovascular, inflammation and pain indications. Therapeutic drugs are developed by using an integrated chemical genomics approach and proprietary chemistries.

The company, headquartered in San Jose CA, is led by Laxminarayan Bhat (President and CEO). Reviva Pharmaceuticals elected to keep its revenues undisclosed.

The company has raised an estimated total of $35.5 million via private unregistered security offerings.

Offering recap
Status: Completed
Company: Reviva Pharmaceuticals
Industry: Pharmaceuticals
Amount offered: $15.83 million
Amount placed: $15.83 million
First sale: 06-12-2014
Data as of: 06-25-2014

For more information visit www.XDATA.co

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s